PROF vs ZTS · rev $10.7M vs P/E 25, rev $9.47B
Profound Medical Corp (PROF) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
Latest reported ZTS revenue for 2025-12-31 was $9.47B. Net income was $2.67B. Revenue was up 2.3% from 2024-12-31 to 2025-12-31. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
PROF currently screens at market cap $238.7M. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the PROF and ZTS stock pages for the full models.
Not investment advice.